Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Galkin Vladimir | LUCY Innovative Eyewear Inc | 13D/A | 50.9% | Sep 20, 2024 | 2y |
| Versant Venture Capital VI, L.P. | GLUE Monte Rosa Therapeutics, Inc. | 13D/A | 8.3% | Sep 20, 2024 | 2y |
| Saba Capital Management, L.P. | VGM Invesco Trust for Investment Grade Municipals | 13D/A | 4.95% | Sep 20, 2024 | 2y |
| Sansone Advisors, LLC | INFU InfuSystem Holdings, Inc | 13D/A | 6.8% | Sep 20, 2024 | 2y |
| Volition Capital Fund IV, L.P. | GROV Grove Collaborative Holdings, Inc. | 13D/A | 27.2% | Sep 20, 2024 | 2y |
| Thomist Capital Management, LP | BTU Peabody Energy Corp | 13D/A | 9.29% | Sep 20, 2024 | 2y |
| Nippon Shinyaku Co., Ltd. | CAPR Capricor Therapeutics, Inc. | 13G/A | 18.9% | Sep 20, 2024 | 2y |
| HL Voting Trust | HLI Houlihan Lokey, Inc. | 13D/A | 23.9% | Sep 20, 2024 | 2y |
| Klaus Umek | CRTO Criteo S.A. | 13D/A | 3.77% | Sep 20, 2024 | 2y |
| PERCEPTIVE ADVISORS LLC | VAPO Vapotherm, Inc. Common Stock | 13D/A | 100% | Sep 20, 2024 | 2y |
| Mason Ward | PARA Parabolic Technologies, Inc. | 13D/A | 19.99% | Sep 20, 2024 | 2y |
| Liberty 77 Capital L.P. | FLG Flagstar Bank, National Association | 13D/A | 18.1% | Sep 20, 2024 | 2y |
| KOONCE CALVIN SCOTT | VSEC Vse Corp | 13D/A | 9.2% | Sep 20, 2024 | 2y |
| Ionic Ventures, LLC | VVOS Vivos Therapeutics, Inc. | 13G | 8.7% | Sep 19, 2024 | 2y |
| Nantahala Capital Management, LLC | CRMT Americas Carmart Inc | 13D | 6.7% | Sep 19, 2024 | 2y |
| MILLENNIUM MANAGEMENT LLC | SILA Sila Realty Trust, Inc. | 13G | 1.7% | Sep 18, 2024 | 2y |
| Thomas A. Satterfield, Jr. | INTT Intest Corp | 13G | 5.35% | Sep 18, 2024 | 2y |
| Zhang Minghui | CHSN Chanson International Holding | 13G | 11.8% | Sep 17, 2024 | 2y |
| VEPF VIII SPV I, L.P. | SMAR Smartsheet Inc. | 13D | 4.65% | Sep 17, 2024 | 2y |
| V Capital Consulting Limited | YFOR YYForce Inc. | 13G | 5.29% | Sep 13, 2024 | 2y |
| Union Square Park Capital Management, LLC | REED Reed's, Inc. | 13D/A | 14.8% | Sep 10, 2024 | 2y |
| TG Investment Ltd. | CFOR CapForce Inc. | 13G/A | 7% | Aug 23, 2024 | 2y |
| Danone S.A. | LWAY Lifeway Foods, Inc. | 13D/A | 23.4% | Sep 23, 2024 | 2y |
| Liberty Broadband Corporation | CHTR Charter Communications, Inc. | 13D/A | 31.9% | Sep 23, 2024 | 2y |
| Riot Platforms, Inc. | KEEL Keel Infrastructure Corp. | 13D/A | 19.9% | Sep 23, 2024 | 2y |
| MASAYA OTSUKA | XPON Expion Energy, Inc. | 13G | 7.62% | Sep 20, 2024 | 2y |
| HORIZON KINETICS ASSET MANAGEMENT LLC | LB LandBridge Corp | 13D/A | 29.5% | Sep 20, 2024 | 2y |
| Skorpios Trust | STOK Stoke Therapeutics, Inc. | 13D/A | 16.9% | Sep 19, 2024 | 2y |
| Galkin Vladimir | LUCY Innovative Eyewear Inc | 13D/A | 47.3% | Sep 19, 2024 | 2y |
| NOVO HOLDINGS A/S | EWTX Edgewise Therapeutics, Inc. | 13D/A | 5.9% | Sep 19, 2024 | 2y |
| Silver Point Capital L.P. | GPOR Gulfport Energy Corp | 13D/A | 30% | Sep 19, 2024 | 2y |
| 8 Rivers Capital, LLC | NPWR Net Power Inc. | 13D/A | 30.6% | Sep 19, 2024 | 2y |
| Saba Capital Management, L.P. | ASA ASA Gold & Precious Metals Ltd | 13D/A | 16.87% | Sep 19, 2024 | 2y |
| MILLENNIUM MANAGEMENT LLC | ADMA Adma Biologics, Inc. | 13G | 0.6% | Sep 19, 2024 | 2y |
| Michael Blitzer | LUNR Intuitive Machines, Inc. | 13D/A | 4% | Sep 19, 2024 | 2y |
| Galkin Vladimir | LUCY Innovative Eyewear Inc | 13D/A | 31.1% | Sep 18, 2024 | 2y |
| Yoshiyuki Aikawa | SBC SBC Medical Group Holdings Inc | 13D/A | 92.3% | Sep 17, 2024 | 2y |
| Galkin Vladimir | LUCY Innovative Eyewear Inc | 13D/A | 26.7% | Sep 17, 2024 | 2y |
| Norwest Venture Partners XVI, LP | MBX MBX Biosciences, Inc. | 13D | 6.4% | Sep 16, 2024 | 2y |
| New Enterprise Associates 17, L.P. | MBX MBX Biosciences, Inc. | 13D | 11.4% | Sep 16, 2024 | 2y |
| Longitude Capital Partners IV, LLC | BCAX Bicara Therapeutics Inc. | 13D | 6% | Sep 16, 2024 | 2y |
| Galkin Vladimir | LUCY Innovative Eyewear Inc | 13D | 21.1% | Sep 16, 2024 | 2y |
| James N. Topper | MBX MBX Biosciences, Inc. | 13D | 18.8% | Sep 16, 2024 | 2y |
| ORBIMED ADVISORS LLC | MBX MBX Biosciences, Inc. | 13D | 12% | Sep 16, 2024 | 2y |
| ENAVATE SCIENCES GP, LLC | BCAX Bicara Therapeutics Inc. | 13D | 9% | Sep 16, 2024 | 2y |
| SR One Capital Management, LLC | ZBIO Zenas BioPharma, Inc. | 13D | 12.3% | Sep 16, 2024 | 2y |
| Deep Track Capital, LP | MBX MBX Biosciences, Inc. | 13G | 9.48% | Sep 13, 2024 | 2y |
| WHITEBOX ADVISORS LLC | UP Wheels Up Experience Inc. | 13G/A | 6.2% | Sep 13, 2024 | 2y |
| Kore Advisors LP | UP Wheels Up Experience Inc. | 13G | 3.7% | Sep 13, 2024 | 2y |
| Quanta Computer Inc. | VUZI Vuzix Corp | 13G | 10.4% | Sep 13, 2024 | 2y |